麻豆精品视频

  • HOME
  • NEWS DESK
  • RESEARCH
  • 麻豆精品视频Review: Obesity and Alzheimer鈥檚 Share Disease Metabolic Pathways

麻豆精品视频Review: Obesity and Alzheimer鈥檚 Share Disease Metabolic Pathways

Brain, Puzzle

Researchers found biological links between obesity and Alzheimer鈥檚, pointing to shared metabolic disruptions that may shape brain health long before symptoms appear.


By gisele galoustian | 5/5/2026

Review Snapshot: As the U.S. population ages and obesity rates rise, researchers are increasingly examining how these trends may intersect to drive Alzheimer鈥檚 disease (AD) risk. A review from 麻豆精品视频, published in the journal Cells, highlights growing evidence that obesity and AD are biologically connected, with fat tissue acting as an active signaling organ that influences brain health. The authors show that both conditions share early metabolic disruptions 鈥 often long before symptoms appear 鈥 suggesting risk may begin much earlier than previously understood.

The findings point to breakdowns in the body鈥檚 energy systems, particularly in mitochondria, along with inflammation and disrupted signaling from fat tissue, as key drivers of brain cell damage and cognitive decline. The review also identifies the gut-brain axis as an important factor, where imbalances in gut bacteria can further fuel inflammation and neurodegeneration. Together, the research supports a shift toward earlier detection and whole-body prevention, emphasizing that maintaining metabolic health may be critical to protecting the brain.

By 2030, the population in the United States aged 65 and older is expected to reach 71 million or about 20% of Americans. This growth is likely to increase the burden of age-related diseases, particularly Alzheimer鈥檚 disease (AD), affecting about 1 in 9 adults over 65.

At the same time, obesity has become increasingly common, including among older adults, where prevalence has nearly doubled in recent decades. Obesity is a major risk factor for metabolic disease, and growing evidence now links it to brain health and dementia risk.

A review from 麻豆精品视频, published in the journal , examines the growing biological links between obesity and AD, highlighting how disruptions in metabolism can influence brain health. It explores the complex pathways through which adipose tissue and whole-body metabolism interact with the central nervous system, shedding light on how these processes may contribute to neurodegeneration and cognitive decline.

The authors synthesize evidence showing that obesity and AD share overlapping metabolic disturbances that arise early in disease progression 鈥 often well before clear clinical symptoms appear.

鈥淥besity and Alzheimer鈥檚 disease are closely connected through the way the body鈥檚 metabolism works,鈥 said , Ph.D., senior author, director of the Center for Molecular Biology and Biotechnology and an associate scientist in the Department of Chemistry and Biochemistry within FAU鈥檚 Charles E. Schmidt College of Science. 鈥淏oth conditions involve similar problems in how fat tissue sends signals, how the body uses insulin and how cells produce energy. Of these, problems in the mitochondria 鈥 the cell鈥檚 energy-producing structures 鈥 appear to be the most important. When mitochondria don鈥檛 work properly, it disrupts energy supply throughout the body and brain, which can contribute directly to brain cell damage and the development of Alzheimer鈥檚 disease.鈥

Mechanistically, the authors explain that both obesity and AD involve breakdowns in the cell鈥檚 main energy systems. Specifically, two key processes inside mitochondria 鈥 the tricarboxylic acid cycle and the electron transport chain 鈥 do not function properly. When these systems are impaired, cells produce less energy and generate higher levels of harmful molecules called reactive oxygen species.

This imbalance creates a state of 鈥渆nergy stress鈥 and oxidative damage, meaning that important parts of the cell such as proteins, lipids and DNA begin to break down. In the brain, this damage contributes to hallmark features of AD, including the buildup of amyloid-尾 and abnormal changes in tau proteins.

At the same time, Allani and Romina Mar铆a Uranga, Ph.D., co-author and an assistant professor of biochemistry at New College, note that obesity adds another layer of risk through disrupted signaling from fat tissue. Fat cells normally send hormones that help regulate metabolism, but in obesity these signals become unbalanced. Combined with chronic, low-grade inflammation throughout the body, this further disrupts communication between the body and brain, increasing vulnerability to neurodegeneration.

鈥淎n important implication of our findings is that these metabolic changes don鈥檛 just appear once disease is established 鈥 they likely begin much earlier,鈥 said Allani, who is also a member of the 麻豆精品视频Stiles-Nicholson Brain Institute. 鈥淚n fact, they may help drive the development of disease before symptoms show up. This makes them potential early warning markers that could help identify individuals at risk. Rather than being late effects of Alzheimer鈥檚 or obesity, we increasingly see these metabolic disruptions as early, upstream changes that set disease processes in motion.鈥

From a translational standpoint, the review highlights mitochondrial function and restoration of gut-brain axis balance as promising targets to help prevent or delay both metabolic and neurodegenerative diseases.

The gut microbiota plays a central role in brain health by shaping metabolism, inflammation and mitochondrial activity. In a balanced state, it supports immune function and produces beneficial compounds such as short-chain fatty acids that help protect neurons and may lower AD risk. When disrupted, however, increased gut permeability allows inflammatory molecules to enter the bloodstream 鈥 fueling brain inflammation, oxidative stress, amyloid and tau pathology, and ultimately neuronal damage, all hallmarks of neurodegeneration.

鈥淒iet, aging, obesity and stress strongly influence core metabolic processes, and unhealthy patterns are linked to higher dementia risk,鈥 said Allani. 鈥淲hile animal studies show strong causal effects, human results are more variable 鈥 but together, the evidence suggests these metabolic processes play an important role in driving Alzheimer鈥檚 and cognitive decline.鈥

The authors note that the mechanistic links described, while well-supported by current evidence, require further validation in clinical settings.

Looking ahead, this integrated view of obesity and AD shifts attention toward earlier detection and whole-body prevention. The review suggests that monitoring metabolic health could identify risk long before symptoms appear, opening the door to earlier and more effective intervention.

It also highlights therapies that act on the body as a whole rather than the brain alone, including improving insulin sensitivity, reducing oxidative stress and regulating adipokines 鈥 chemical signals released by fat cells that help control metabolism, hunger and inflammation.

鈥淲hat emerges from this research is a shift in perspective 鈥 from treating obesity and Alzheimer鈥檚 as separate conditions to understanding them as interconnected processes rooted in metabolic health,鈥 said Allani. 鈥淭his opens the door to earlier, more comprehensive interventions that target the underlying biology shared by both diseases, rather than responding only after damage has already occurred.鈥

-FAU-